Cargando…

Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses

Two polymorphs of the title compound, C(19)H(16)N(2)O(3), were obtained from ethano­lic (polymorph I) and methano­lic solutions (polymorph II), respectively. Both polymorphs crystallize in the monoclinic system with four formula units per cell and a complete mol­ecule in the asymmetric unit. The mai...

Descripción completa

Detalles Bibliográficos
Autores principales: Daoui, Said, Baydere, Cemile, Chelfi, Tarik, El Kalai, Fouad, Dege, Necmi, Karrouchi, Khalid, Benchat, Noureddine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057381/
https://www.ncbi.nlm.nih.gov/pubmed/32148889
http://dx.doi.org/10.1107/S2056989020002406
_version_ 1783503643792637952
author Daoui, Said
Baydere, Cemile
Chelfi, Tarik
El Kalai, Fouad
Dege, Necmi
Karrouchi, Khalid
Benchat, Noureddine
author_facet Daoui, Said
Baydere, Cemile
Chelfi, Tarik
El Kalai, Fouad
Dege, Necmi
Karrouchi, Khalid
Benchat, Noureddine
author_sort Daoui, Said
collection PubMed
description Two polymorphs of the title compound, C(19)H(16)N(2)O(3), were obtained from ethano­lic (polymorph I) and methano­lic solutions (polymorph II), respectively. Both polymorphs crystallize in the monoclinic system with four formula units per cell and a complete mol­ecule in the asymmetric unit. The main difference between the mol­ecules of (I) and (II) is the reversed position of the hy­droxy group of the carb­oxy­lic function. All other conformational features are found to be similar in the two mol­ecules. The different orientation of the OH group results in different hydrogen-bonding schemes in the crystal structures of (I) and (II). Whereas in (I) inter­molecular O—H⋯O hydrogen bonds with the pyridazinone carbonyl O atom as acceptor generate chains with a C(7) motif extending parallel to the b-axis direction, in the crystal of (II) pairs of inversion-related O—H⋯O hydrogen bonds with an R (2) (2)(8) ring motif between two carb­oxy­lic functions are found. The inter­molecular inter­actions in both crystal structures were analysed using Hirshfeld surface analysis and two-dimensional fingerprint plots.
format Online
Article
Text
id pubmed-7057381
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-70573812020-03-06 Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses Daoui, Said Baydere, Cemile Chelfi, Tarik El Kalai, Fouad Dege, Necmi Karrouchi, Khalid Benchat, Noureddine Acta Crystallogr E Crystallogr Commun Research Communications Two polymorphs of the title compound, C(19)H(16)N(2)O(3), were obtained from ethano­lic (polymorph I) and methano­lic solutions (polymorph II), respectively. Both polymorphs crystallize in the monoclinic system with four formula units per cell and a complete mol­ecule in the asymmetric unit. The main difference between the mol­ecules of (I) and (II) is the reversed position of the hy­droxy group of the carb­oxy­lic function. All other conformational features are found to be similar in the two mol­ecules. The different orientation of the OH group results in different hydrogen-bonding schemes in the crystal structures of (I) and (II). Whereas in (I) inter­molecular O—H⋯O hydrogen bonds with the pyridazinone carbonyl O atom as acceptor generate chains with a C(7) motif extending parallel to the b-axis direction, in the crystal of (II) pairs of inversion-related O—H⋯O hydrogen bonds with an R (2) (2)(8) ring motif between two carb­oxy­lic functions are found. The inter­molecular inter­actions in both crystal structures were analysed using Hirshfeld surface analysis and two-dimensional fingerprint plots. International Union of Crystallography 2020-02-25 /pmc/articles/PMC7057381/ /pubmed/32148889 http://dx.doi.org/10.1107/S2056989020002406 Text en © Daoui et al. 2020 http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/4.0/
spellingShingle Research Communications
Daoui, Said
Baydere, Cemile
Chelfi, Tarik
El Kalai, Fouad
Dege, Necmi
Karrouchi, Khalid
Benchat, Noureddine
Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses
title Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses
title_full Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses
title_fullStr Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses
title_full_unstemmed Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses
title_short Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses
title_sort polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-di­hydro­pyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and hirshfeld surface analyses
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057381/
https://www.ncbi.nlm.nih.gov/pubmed/32148889
http://dx.doi.org/10.1107/S2056989020002406
work_keys_str_mv AT daouisaid polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses
AT bayderecemile polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses
AT chelfitarik polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses
AT elkalaifouad polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses
AT degenecmi polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses
AT karrouchikhalid polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses
AT benchatnoureddine polymorphismof25benzyl6oxo3phenyl16dihydropyridazin1ylaceticacidwithtwomonoclinicmodificationscrystalstructuresandhirshfeldsurfaceanalyses